SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Shorting stocks: Broken stocks - Analysis -- Ignore unavailable to you. Want to Upgrade?


To: drakes353 who wrote (919)3/11/1998 3:07:00 PM
From: xbrent  Read Replies (1) | Respond to of 2506
 
I think that BKE cannot continue the upward trend that it has been on.It is too early to short yet. In my opinion this fashion retailer will fall out of fashion before long. I am watching chart for nice clear down signal.



To: drakes353 who wrote (919)3/13/1998 2:42:00 AM
From: Q.  Read Replies (1) | Respond to of 2506
 
Drakes, re. phone numbers for news agencies: For Reuters, you want the Washington bureau, which covers SEC filings. Call them and tell them about the filing, and they might look it up and run a story. I did this successfully once with one co. whose auditor quit over a dispute, and the stock actually fell in response to the story, although other times I tried it, the Reuters reporter asked me if I was a short-seller, and then she did nothing. I don't have the Reuters Washington bureau phone no. anymore, but you can phone any Reuters bureau at a phone no. listed at the bottom of any Reuters story (for example at Yahoo) and ask for it.

Bloomberg's editorial phone no.'s can be found similarly, if you have a Bloomberg terminal. Probably you want to reach their main editorial desk, which I think is in New Jersey.



To: drakes353 who wrote (919)3/17/1998 5:18:00 AM
From: Q.  Read Replies (1) | Respond to of 2506
 
basea filed a 10Q for 2 mos ending 12/31. (They are changing their fiscal year.)

Here's the mgmt. comment on its losses:

Continuing Losses

The Company incurred a loss from continuing operations before taxes of
$3.2 million in the two months ended December 31, 1997, compared to a $1.7
million loss for the quarter ended January 31, 1997. The increased loss was
primarily due to low revenues, coupled with a significant increase in cost of
sales, more specifically, the increased software development salary and
labor-related expenditures of $0.9 million, which are primarily being expensed,
and not capitalized, as in the period ended January 31, 1997. Amortization
expense also increased significantly to $0.6 million, compared to $0.3 million
in the period ended January 31, 1997. The Company expects additional losses in
1998,
including amortization expense currently estimated to be $3.3 million.*
The Company's ability to achieve profitable operations is dependent upon, among
other things, the completion of current development and testing activities for
PHARM2 and FlowStream, timely delivery and successful installation and
validation of its systems by its customers, and successful competition in the
markets in which the Company participates.*